Established evidence from animal and in vitro studies supports the pathological role of LPS in hypertension through the activation of TLR4 receptor and, hence, the resulting activation of NADPH oxidase and an inducement of production of series of pro-inflammatory cytokines in vascular endothelium [49]. The gene discussed is FMO5; the disease is Hypertension.